AMBALAL SARABHAI ENTERPRISES
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.45 | 6.16 | 3.83 | 1.83 | 0.55 |
| CEPS(Rs) | 1.81 | 6.46 | 4.15 | 2.35 | 0.54 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 17.08 | 15.64 | 9.64 | 5.84 | 4.00 |
| Tax Rate(%) | 25.12 | 12.87 | 9.79 | 5.38 | 66.46 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 5.04 | 12.50 | -0.92 | -1.38 | 3.83 |
| EBIT Margin(%) | 10.00 | 27.86 | 21.39 | 14.41 | 6.03 |
| Pre Tax Margin(%) | 8.46 | 26.85 | 19.47 | 11.80 | 3.89 |
| PAT Margin (%) | 6.33 | 23.39 | 17.57 | 11.17 | 1.30 |
| Cash Profit Margin (%) | 7.90 | 24.54 | 19.01 | 13.02 | 2.67 |
| Performance Ratios | |||||
| ROA(%) | 4.67 | 21.57 | 15.02 | 7.84 | 0.99 |
| ROE(%) | 8.85 | 48.74 | 49.47 | 40.95 | 7.01 |
| ROCE(%) | 11.08 | 45.53 | 40.28 | 27.14 | 13.17 |
| Asset Turnover(x) | 0.74 | 0.92 | 0.86 | 0.70 | 0.76 |
| Sales/Fixed Asset(x) | 2.04 | 2.89 | 2.44 | 2.06 | 2.34 |
| Working Capital/Sales(x) | 8.17 | 13.71 | -21.02 | -4.69 | -2.79 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.35 | 0.41 | 0.49 | 0.43 |
| Receivable days | 57.49 | 60.46 | 73.84 | 83.82 | 81.74 |
| Inventory Days | 33.90 | 28.13 | 35.41 | 41.50 | 34.90 |
| Payable days | 149.28 | 155.45 | 165.09 | 199.78 | 176.52 |
| Valuation Parameters | |||||
| PER(x) | 14.16 | 5.66 | 4.61 | 10.38 | 25.77 |
| PCE(x) | 11.34 | 5.40 | 4.26 | 8.11 | 26.71 |
| Price/Book(x) | 1.20 | 2.23 | 1.83 | 3.26 | 3.58 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.99 | 1.35 | 0.80 | 1.17 | 0.83 |
| EV/Core EBITDA(x) | 7.93 | 3.94 | 4.53 | 6.92 | 11.14 |
| EV/EBIT(x) | 9.65 | 4.71 | 3.68 | 7.81 | 13.66 |
| EV/CE(x) | 0.69 | 1.15 | 0.63 | 0.85 | 0.60 |
| M Cap / Sales | 0.92 | 1.36 | 0.83 | 1.09 | 0.72 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -13.45 | 20.23 | 22.58 | -12.10 | 21.50 |
| Core EBITDA Growth(%) | -68.28 | 131.58 | 29.13 | 98.01 | -14.63 |
| EBIT Growth(%) | -68.82 | 57.35 | 79.39 | 115.17 | -17.19 |
| PAT Growth(%) | -76.49 | 60.86 | 90.17 | 670.90 | 84.65 |
| EPS Growth(%) | -76.49 | 60.85 | 108.76 | 230.92 | 232.62 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.31 | 0.21 | 0.37 | 0.70 | 1.31 |
| Current Ratio(x) | 1.23 | 1.14 | 0.94 | 0.78 | 0.68 |
| Quick Ratio(x) | 1.04 | 1.00 | 0.81 | 0.66 | 0.59 |
| Interest Cover(x) | 6.47 | 27.54 | 11.17 | 5.52 | 2.81 |
| Total Debt/Mcap(x) | 0.26 | 0.10 | 0.20 | 0.21 | 0.37 |
Compare Financial Ratios of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹367.8 Cr | 1.4% | 6.3% | 119.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
| CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 1.4% |
6.3% |
119.7% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
